Evidence map›Paper›PMID 24726166›Full record

Trial reportInternational journal of cardiology2014

Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.

Christopher Adlbrecht, Kurt Huber, Harmony R Reynolds, Antonio C Carvalho, Vladimír Džavík, Philippe Gabriel Steg, Li Liu, Paolo Marino, Camille A Pearte, James M Rankin and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 7 countries.

Christopher AdlbrechtDepartment of Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Kurt Huber3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria.
Harmony R ReynoldsCardiovascular Clinical Research Center, New York University School of Medicine, New York, United States.
Antonio C CarvalhoHospital Sao Paulo, Moema, Sao Paulo, Brazil.
Vladimír DžavíkPeter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Philippe Gabriel StegINSERM U-698, Paris, France; Université Paris-Diderot, Paris, France; Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard, Paris, France.
Li LiuClinical Trial and Surveys Corp., Baltimore, United States.
Paolo MarinoUniversity of Verona/Instituti Ospedalieri, Verona, Italy.
Camille A PearteCardiovascular Clinical Research Center, New York University School of Medicine, New York, United States.
James M RankinPerth Cardiovascular Institute, Perth, Australia.
Harvey D WhiteGreen Lane Cardiovascular Service, Auckland, New Zealand.
Gervasio A LamasGreen Lane Cardiovascular Service, Auckland, New Zealand.
Judith S HochmanCardiovascular Clinical Research Center, New York University School of Medicine, New York, United States. Electronic address: Judith.Hochman@nyumc.org.
New York University · USGreenlane Clinical Centre · NZAssistance Publique – Hôpitaux de Paris · FRClinical Trials and Surveys Corporation · USHospital São Paulo · BRMedical University of Vienna · ATUniversity Health Network · CAUniversity of Verona · ITWilhelminen Hospital · AT

Funding

Occluded Artery Trial: Long Term Follow-UpU01HL062509 · NHLBI · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI HOCHMAN, JUDITH S · 1999 to 2010
$11.1M
Occluded Artery Trial: Long-Term Follow up-Data Coordinating CenterU01HL062511 · NHLBI · MARYLAND MEDICAL RESEARCH INSTITUTE, INC · PI FORMAN, SANDRA · 1999 to 2010
$5.2M
NHLBI NIH HHS U01 HL062509NHLBI NIH HHS U01 HL062511
6 · The paper itself

Abstract

backgroundThe Occluded Artery Trial (OAT) randomized stable patients (n=2201)>24 h (calendar days 3-28) after myocardial infarction (MI) with totally occluded infarct-related arteries (IRA), to percutaneous coronary intervention (PCI) with optimal medical therapy, or optimal medical therapy alone (MED). PCI had no impact on the composite of death, reinfarction, or class IV heart failure over extended follow-up of up to 9 years. We evaluated the impact of early and late reinfarction and definition of MI on subsequent mortality. METHODS AND

resultsReinfarction was adjudicated according to an adaptation of the 2007 universal definition of MI and the OAT definition (≥2 of the following--symptoms, EKG and biomarkers). Cox regression models were used to analyze the effect of post-randomization reinfarction and baseline variables on time to death. After adjustment for baseline characteristics the 169 (PCI: n=95; MED: n=74) patients who developed reinfarction by the universal definition had a 4.15-fold (95% CI 3.03-5.69, p<0.001) increased risk of death compared to patients without reinfarction. This risk was similar for both treatment groups (interaction p=0.26) and when MI was defined by the stricter OAT criteria. Reinfarctions occurring within 6 months of randomization had similar impact on mortality as reinfarctions occurring later, and the impact of reinfarction due to the same IRA and a different epicardial vessel was similar.

conclusionsFor stable post-MI patients with totally occluded infarct arteries, reinfarction significantly independently increased the risk of death regardless of the initial management strategy (PCI vs. MED), reinfarction definition, location and early or late occurrence.

Indexed as

Coronary OcclusionFemaleFollow-Up StudiesHumansMaleMiddle AgedMyocardial InfarctionRecurrenceTime FactorsLate revascularizationMortalityMyocardial infarctionReinfarction

Identifiers

PMID24726166
PMCPMC4067126
OpenAlexW2118301759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.